Record · Provider
Sunil Babu
Fort Wayne, IN. NPI 1891968301. Medical Oncology.
What was reported, 2019–2025
- $165,617
- General payments
- 395 separate payments. What they were, as CMS records them, is below.
- $43,892
- Research payments
- Funding for a study, usually paid to an institution with this doctor named on it. Not added to general payments, and not income.
- $9,000
- Ownership and investment
- The value of a stake this doctor or an immediate family member held.
- 0
- Disputed
- This doctor has contested none of the payments reported about them.
How this compares
- General payments: $165,617, 2019–2025
- By the amount companies reported, 332nd among the 4,724 profiles with general payments in Medical Oncology.
General payments: this profile's rank in each group, its place among the profiles nationally and its share of the national total Nationally 14,447th of 1,688,859 In Indiana 241st of 32,621 In Medical Oncology 332nd of 4,724 Profiles below it nationally More than 99% Share of the national total < 0.1% - Research payments: $43,892, 2019–2025
- By the amount companies reported, 71st among the 991 profiles named on research payments in Medical Oncology.
Research payments: this profile's rank in each group, its place among the profiles nationally and its share of the national total Nationally 2,719th of 22,827 In Indiana 45th of 334 In Medical Oncology 71st of 991 Profiles below it nationally More than 88% Share of the national total < 0.1% - Ownership and investment: $9,000, 2019–2025
- By the amount companies reported, 10th among the 22 profiles with ownership or investment interests in Medical Oncology.
Ownership and investment: this profile's rank in each group, its place among the profiles nationally and its share of the national total Nationally 2,565th of 3,979 In Indiana 60th of 97 In Medical Oncology 10th of 22 Profiles below it nationally More than 35% Share of the national total < 0.1%
What the payments were
1 more column on a wider screen
| Nature of payment | Amount |
|---|---|
| Consulting Fee | $97,531 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,940 |
| Travel and Lodging | $20,335 |
| Honoraria | $13,486 |
| Food and Beverage | $12,075 |
| Education | $251 |
Each payment as the manufacturer categorized it when reporting it to CMS, across 2019–2025. Together they are the general payments above. A category is the reporter’s, and nothing in the record says a payment in any of them was improper.
By program year
2 more columns on a wider screen
| Program year | General | Research |
|---|---|---|
| 2025 | $27,389 | $3,446 |
| 2024 | $13,664 | $0 |
| 2023 | $21,189 | $0 |
| 2022 | $20,681 | $0 |
| 2021 | $25,378 | $2,474 |
| 2020 | $20,864 | $10,355 |
| 2019 | $36,453 | $27,617 |
CMS reports a program year at a time and also publishes its own total across them, which is what the figures above are. These rows are that total taken apart, not a second set of payments.
The record
- National Provider Identifier
- 1891968301
- The identifier this page is addressed by, and the one both CMS files share.
- Licensed in
- IN
- The state of the license CMS lists first.
- Recipient type
- Covered Recipient Physician
- How CMS classifies the recipient of these payments.
Medicare prescribing
What this provider billed to Medicare Part D in 2024, as CMS published it. Medicare Part D only: what they prescribed outside it is not here.
- 857
- Claims
- Prescriptions and refills billed to Part D, as CMS counts them.
- $3,548,541
- Total drug cost
- What Part D, the plan and the patient paid together. Not what this provider was paid — they are paid nothing out of it.
- 161
- Beneficiaries
- People with at least one prescription from this provider.
- Withheld
- Brand-name claims
- Of the claims above, those for a brand-name drug. CMS withheld this value and marked it "#". It publishes two markers and two reasons — a value between 1 and 10, or one withheld so another cannot be worked out — without saying which marker means which.
- 500
- Generic claims
- Of the claims above, those for a generic.
- 24
- Opioid claims
- CMS puts this provider's opioid prescribing rate at 2.8004667444574096% of their claims. That is their figure, computed from their own unsuppressed data.
- 26
- Antibiotic claims
- Claims for an antibiotic.
- Hematology-Oncology
- Prescriber type
- As CMS classifies this prescriber. Credentials: M.D..
A blank is not a zero. CMS withholds a value between 1 and 10, and withholds the next lowest alongside it so the first cannot be worked out by subtraction — so a withheld figure is not even evidence that the number was small. Rows for ten or fewer claims are removed from the file altogether, which is why the parts of a total can be withheld while the total is published.
Elsewhere
- Payments to doctors in Indiana — what was reported across the state this doctor practises in.
- What drug and device companies pay doctors — the national picture these figures are part of.
- This record at CMS — the publisher’s own page for this profile.
- The NPI registry — who this identifier belongs to, at CMS.
Data retrieved
Sources
- Open Payments — payments grouped by physician — Centers for Medicare & Medicaid Services · U.S. Government work · retrieved September 25, 2026
Compiled automatically from Open Payments — payments grouped by physician by a checked SQL query · Editor: Kian O'Connor · How this site is built